Pharmacy cost management is becoming one of the most important financial decisions inside an employer health plan. Yet many employers still receive one renewal number, one pharmacy line item, and very little explanation of what actually changed.
In this episode of Blueprints for Better Benefits, Rodney Mattos Jr. and Rodney Mattos Sr. break down why pharmacy spending is rising, how biosimilars and GLP-1 coverage are reshaping employer budgets, and why PBM transparency matters more than ever for companies trying to control healthcare costs without cutting meaningful employee access.
The conversation explains how biosimilars can create real savings opportunities when contract terms, formulary placement, and net cost reporting actually pass the value back to the plan. It also looks at GLP-1 coverage as a growing pressure point for employers, especially when demand rises faster than budgets can absorb.
For employers with self-funded health plans, pharmacy cannot be treated as a hidden subcategory inside the renewal. It needs governance, data, contract review, clinical standards, employee communication, and a clear financial model. Rodney Jr. and Rodney Sr. explain how CFOs, HR leaders, legal teams, and benefits committees can work together to ask better questions, protect employees, and build a pharmacy strategy that supports long-term plan ownership.
Biosimilars
Biosimilars can offer safe and effective competition for certain high-cost biologic medicines, but savings do not automatically reach the employer. The episode explains why formulary placement, rebate terms, care setting, and net cost reporting determine whether biosimilar competition actually lowers plan costs.
GLP-1 Coverage
GLP-1 coverage is not a simple yes-or-no decision. Employers need clear eligibility rules, clinical monitoring, outcome review, employee communication, and budget modeling to support the right patients while protecting the sustainability of the health plan.
PBM Transparency
PBM transparency is critical because discounts, rebates, spread pricing, affiliate arrangements, and specialty pharmacy contracts can make the true cost of a medicine hard to see. Rodney explains why employers should ask where every dollar goes and whether the contract serves the plan, the vendor, or both.
Self-Funded Health Plan
A self-funded health plan gives employers more authority over data, contracts, vendors, and plan design. But ownership also creates responsibility. This episode shows how employers can use that responsibility to manage pharmacy costs with evidence instead of guesswork.
In This Episode, We Cover
- Why pharmacy is becoming one of the largest financial decisions inside an employer health plan
- How biosimilars create savings opportunities, and why those savings are not automatic
- Why GLP-1 coverage needs a clinical operating plan, not a light-switch decision
- What employers should ask PBMs, carriers, and pharmacy vendors before renewal
- How rebates, spread pricing, and affiliate relationships can affect true net cost
- Why self-funded employers need pharmacy data across both medical and pharmacy claims
- How CFOs, HR leaders, legal teams, and benefits committees should share responsibility
- The importance of employee communication before formulary or coverage changes
- Why contract review should begin six to nine months before renewal
- How employers can move from reacting to pharmacy increases to governing them with clarity
Explore More
- Explore our insurance agency, Triforta: https://www.triforta.com/
- Learn more about our software for insurance agencies, Apeironix: https://apeironix.com
- Visit the full podcast website, The Rodney Mattos Show: https://rodneymattos.com/
Connect with Rodney
Email: rmattos@triforta.com
LinkedIn: https://www.linkedin.com/in/rodneymattos